Isabel Tanjeong 150 mg (Irbesartan)
Irbesartan 150mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
MFDS item code 201101643 · Approved 2011.03.23
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
This medication is used for patients with essential hypertension, i.e., primary hypertension. It is also beneficial for treating kidney disease caused by hypertension in patients with type 2 diabetes. Therefore, it is effectively used for managing hypertension and preventing complications of diabetes.
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.
This medication must not be administered to pregnant women as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, use should be discontinued immediately. Individuals with allergies to this medication or its components should not take it. Also, patients with severe liver disease, those with hereditary angioedema or a history of angioedema while on ACE inhibitors or angiotensin II receptor antagonists should avoid this medication. Patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also not be administered this medication. For diabetic patients with moderate to severe renal impairment or those on ACE inhibitors for diabetic nephropathy, it is advisable to avoid this medication in combination. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, specific heart diseases, patients with volume depletion, renal artery hypertension, and patients with renal dysfunction should use this medication cautiously, with regular monitoring of blood pressure, renal function, and electrolyte status. Generally, this medication has mild and temporary side effects, but symptoms such as headaches, dizziness, fatigue, diarrhea, and rash may occur. Rarely, severe side effects such as angioedema, hyperkalemia, renal failure, liver dysfunction, hypoglycemia, and rhabdomyolysis may occur, so immediate consultation with a doctor is required if any unusual symptoms appear. This medication can be used in conjunction with other antihypertensives, but caution is needed when taken with potassium supplements or potassium-sparing diuretics as it may increase the risk of high potassium levels. When combined with lithium, lithium levels may rise, so serum lithium levels should be monitored closely during co-administration. Co-administration with non-steroidal anti-inflammatory drugs (NSAIDs) may reduce blood pressure-lowering effects and worsen renal function, so caution is particularly needed for the elderly or patients with decreased blood volume. This medication is prohibited for use in pregnant women, and it is recommended to discontinue breastfeeding if lactating. Safety and efficacy in children have not been established, so it is advisable not to use it in pediatric patients. In cases of overdose, symptoms such as hypotension, tachycardia, and bradycardia may occur, and if experienced, immediate treatment is required; it is not removed by dialysis. This medication should be stored out of the reach of children, and transferring it to another container may compromise quality, which should be avoided. Dizziness or fatigue may occur when driving or operating machinery, so caution is necessary. Patients undergoing diabetes treatment may experience hypoglycemic symptoms, so thorough blood glucose management is required, and dosage adjustments for diabetes medications may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent air and moisture exposure. Additionally, it should be kept in a cool, dry place at or below 30 degrees Celsius to maintain its efficacy.
For domestic use: white or nearly white oval film-coated tablets that are convex on both sides For export: oval film-coated tablets that are white or nearly white
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Irbesartan 150mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.